|
.
|
AOBO Signs LOI to Expand Distribution Into Europe
February 26, 2003 08:09:00 AM ET
HONG KONG, Feb. 26 /PRNewswire-FirstCall/ -- American Oriental Bioengineering Inc. (OTC Bulletin Board: AOBO) a leading Chinese nutraceutical company announced today
that it has signed a letter of intent with Jem Technical Support Services ("JTSS"), a health food distributor in the United Kingdom for product sales and distribution in the UK and Europe.
According to Mr. Tony Liu, CEO of American Oriental Bioengineering, "We believe that our health food and soybean protein peptide products are extremely competitive in terms of both product quality and pricing.
The market potential for nutraceutical products in the United Kingdom market is tremendous and we feel this agreement will result in positive developments that will serve as a catalyst for the launch of AOBO's
products into the European market. The United Kingdom is familiar with Chinese products based on its long standing relationship with China and Hong Kong."
About American Oriental Bioengineering, Inc.
AOBO is a leading Chinese nutraceutical company that uses proprietary processes for producing soybean protein peptide more efficiently than traditional extracting techniques. These techniques are used to
manufacture and formulate supplemental and medicinal products. Soybean peptides are used widely in general food and health food products, sports foods, medicines, fermentation industry and in environmental
protection applications. The Company sees significant opportunities for the marketing of these soybean products and many of their other bioengineered products.
Safe Harbor Statement
Except for the
historical statements made herein, the statements made in this release are forward-looking statements, including. Risk factors that could cause actual results to differ materially from those projected in
forward-looking statements include, but are not limited to, general business conditions, managing growth, and political and other business risks. All forward-looking statements are expressly qualified in their
entirety by this Cautionary Statement and the risks and other factors detailed in the Company's reports filed with the Securities and Exchange Commission.
China Contact: Lily Li
86-451-6666601
F: 86-451-6690967
[EMAIL PROTECTED]
Hong Kong Contact: Clarence Chan
852-9522-3111
F: 852-2829-7410
[EMAIL PROTECTED]
Investor Contact: Harvey Goralnick/David Zazoff
FOCUS Partners LLC
212-752-9445
[EMAIL PROTECTED]
© 2003 PRNewswire
AOBO Completes Purchase of Soybean Protein Peptide Project
January 28, 2003 12:06:00 PM ET
HONG KONG, Jan. 28 /PRNewswire-FirstCall/ -- American Oriental Bioengineering Inc. (OTC Bulletin Board: AOBO)
announced that its board of directors has approved the completion of the Soybean Protein Peptide project purchase, worth an estimated $40 million, effective immediately.
AOBO Completes Purchase of Soybean Protein Peptide Project
12:06 pm - PR Newswire
Friday January 24, 2003
AOBO Expects to Have a Total of 65 Enuresis Soft Gel Clinics Operating in 2003
9:14 am - PR Newswire
Tuesday January 14, 2003
AOBO Expands Into Japan; Signs LOI to Export Its Soybean Protein Peptide Products
9:28 am - PR Newswire
Monday January 6, 2003
AOBO Enters the Hong Kong Market
10:25 am - PR Newswire
|
